Publications

The Origins of Totalitarianism

Essai philosophique en trois parties, la premiere sur l'antisemitisme, la deuxieme sur l'imperialisme a la fin du XIXe s., la troisieme sur le totalitarisme stalinien et nazi

Incidence of thrombotic complications in critically ill ICU patients with COVID-19

The PRISMA 2020 statement: an updated guideline for reporting systematic reviews

Background: The Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) Statement, published in 2009, was designed to help systematic reviewers transparently...

TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells

Colorectal cancer statistics, 2020

Abstract Colorectal cancer (CRC) is the second most common cause of cancer death in the United States. Every 3 years, the American Cancer Society provides an update of CRC occur...

RETRACTED: Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial

Using social and behavioural science to support COVID-19 pandemic response

Post-acute COVID-19 syndrome

Progress, Challenges, and Opportunities in Two-Dimensional Materials Beyond Graphene

Graphene's success has shown that it is possible to create stable, single and few-atom-thick layers of van der Waals materials, and also that these materials can exhibit fascina...

2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD

2019 ESC Guidelines on Diabetes, Pre-Diabetes and Cardiovascular Diseases developed in collaboration with the EASD

eggNOG 5.0: a hierarchical, functionally and phylogenetically annotated orthology resource based on 5090 organisms and 2502 viruses

eggNOG is a public database of orthology relationships, gene evolutionary histories and functional annotations. Here, we present version 5.0, featuring a major update of the und...

Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure

Among patients receiving recommended therapy for heart failure, those in the empagliflozin group had a lower risk of cardiovascular death or hospitalization for heart failure th...